Given the following information, prepare a trial balance for Merck & Co., Inc. as of December 30, 2023:

Account	Debit ($)	Credit ($)
Cash	$280,000,000
Accounts Receivable	$275,000,000
Inventory	$250,000,000
Equipment	$950,000,000
Accumulated Depreciation		$460,000,000
Accounts Payable		$400,115,000
Notes Payable		$880,000,000
Common Stock		$1,050,000,000
Retained Earnings		$483,852,000
Sales Revenue		$1,150,000,000
Cost of Goods Sold	$575,000,000
Operating Expenses	$410,258,000